Gilead Sciences Inc (GILD)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart

Ticker: GILD Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2025-03-18	2025-03-17	PS Planned sale	Dickinson Andrew D Chief Financial Officer Officer	2,500 -1.4% 110.53 USD 276,325	2,500 -1.4%	110.53	USD 276,325
2025-03-12	2025-03-10	PS Planned sale	Dickinson Andrew D Chief Financial Officer Officer	13,013 -7.1% 118.50 USD 1,542,055	13,013 -7.1%	118.50	USD 1,542,055
2025-03-12	2025-03-10	PS Planned sale	Dickinson Andrew D Chief Financial Officer Officer	4,916 -2.6% 117.30 USD 576,641	4,916 -2.6%	117.30	USD 576,641
2025-02-19	2025-02-18	PS Planned sale	Dickinson Andrew D Chief Financial Officer Officer	2,500 -1.5% 104.09 USD 260,225	2,500 -1.5%	104.09	USD 260,225
2025-02-13	2025-02-12	PS Planned sale	Dickinson Andrew D Chief Financial Officer Officer	137,676 -44.6% 102.22 USD 14,073,241	137,676 -44.6%	102.22	USD 14,073,241
2025-02-03	2025-01-31	PS Planned sale	Dickinson Andrew D Chief Financial Officer Officer	142,180 -52.3% 97.22 USD 13,822,740	142,180 -52.3%	97.22	USD 13,822,740
2025-01-16	2025-01-15	PS Planned sale	Dickinson Andrew D Chief Financial Officer Officer	2,500 -1.9% 91.35 USD 228,375	2,500 -1.9%	91.35	USD 228,375
2024-12-17	2024-12-16	PS Planned sale	Dickinson Andrew D Chief Financial Officer Officer	8,500 -6.0% 91.96 USD 781,660	8,500 -6.0%	91.96	USD 781,660
2024-12-03	2024-11-29	PS Planned sale	Dickinson Andrew D Chief Financial Officer Officer	127,930 -47.9% 92.76 USD 11,867,119	127,930 -47.9%	92.76	USD 11,867,119
2024-12-03	2024-11-29	PS Planned sale	Dickinson Andrew D Chief Financial Officer Officer	120,715 -31.1% 92.77 USD 11,198,151	120,715 -31.1%	92.77	USD 11,198,151
2024-11-29	2024-11-27	S Sale	Parsey Merdad Chief Medical Officer Officer	10,399 -11.4% 92.00 USD 956,708	10,399 -11.4%	92.00	USD 956,708
2024-11-29	2024-11-27	S Sale	Parsey Merdad Chief Medical Officer Officer	3,199 -3.4% 91.80 USD 293,679	3,199 -3.4%	91.80	USD 293,679
2024-11-29	2024-11-27	S Sale	Parsey Merdad Chief Medical Officer Officer	5,200 -5.2% 91.80 USD 477,381	5,200 -5.2%	91.80	USD 477,381
2024-11-29	2024-11-27	S Sale	Parsey Merdad Chief Medical Officer Officer	88,119 -46.9% 92.00 USD 8,106,948	88,119 -46.9%	92.00	USD 8,106,948
2024-11-29	2024-11-27	S Sale	Parsey Merdad Chief Medical Officer Officer	57,294 -23.4% 91.79 USD 5,259,297	57,294 -23.4%	91.79	USD 5,259,297
2024-11-27	2024-11-26	S Sale	Bluestone Jeffrey Non-Executive Director	6,788 -43.2% 91.39 USD 620,356	6,788 -43.2%	91.39	USD 620,356
2024-11-07	2024-11-06	PS Planned sale	Mercier Johanna Chief Commercial Officer Officer	5,000 -6.4% 91.28 USD 456,400	5,000 -6.4%	91.28	USD 456,400
2024-11-07	2024-11-06	PS Planned sale	Parsey Merdad Chief Medical Officer Officer	5,000 -4.8% 91.50 USD 457,500	5,000 -4.8%	91.50	USD 457,500
2024-11-07	2024-11-06	PS Planned sale	Parsey Merdad Chief Medical Officer Officer	20,590 -16.4% 91.50 USD 1,883,985	20,590 -16.4%	91.50	USD 1,883,985
2024-10-02	2024-10-01	PS Planned sale	Parsey Merdad Chief Medical Officer Officer	2,000 -2.0% 83.83 USD 167,660	2,000 -2.0%	83.83	USD 167,660
2024-09-13	2024-09-12	PS Planned sale	Parsey Merdad Chief Medical Officer Officer	21,246 -17.2% 84.50 USD 1,795,287	21,246 -17.2%	84.50	USD 1,795,287
2024-09-13	2024-09-12	PS Planned sale	Mercier Johanna Chief Commercial Officer Officer	13,432 -14.7% 83.25 USD 1,118,214	13,432 -14.7%	83.25	USD 1,118,214
2024-09-13	2024-09-12	PS Planned sale	Mercier Johanna Chief Commercial Officer Officer	15,925 -14.8% 84.23 USD 1,341,363	15,925 -14.8%	84.23	USD 1,341,363
2024-08-29	2024-08-28	PS Planned sale	Mercier Johanna Chief Commercial Officer Officer	9,513 -8.3% 78.03 USD 742,299	9,513 -8.3%	78.03	USD 742,299
2024-08-14	2024-08-13	PS Planned sale	Mercier Johanna Chief Commercial Officer Officer	5,490 -4.6% 73.98 USD 406,150	5,490 -4.6%	73.98	USD 406,150
2024-07-01	2024-07-01	PS Planned sale	Parsey Merdad Chief Medical Officer Officer	2,000 -2.0% 68.63 USD 137,260	2,000 -2.0%	68.63	USD 137,260
2024-04-02	2024-04-01	PS Planned sale	Parsey Merdad Chief Medical Officer Officer	2,000 -2.0% 72.96 USD 145,920	2,000 -2.0%	72.96	USD 145,920
2024-02-29	2024-02-29	PS Planned sale	Parsey Merdad Chief Medical Officer Officer	8,230 -8.2% 72.74 USD 598,624	8,230 -8.2%	72.74	USD 598,624
2024-02-29	2024-02-28	PS Planned sale	Parsey Merdad Chief Medical Officer Officer	2,000 -1.9% 73.18 USD 146,360	2,000 -1.9%	73.18	USD 146,360
2024-01-17	2024-01-16	PS Planned sale	Dickinson Andrew D Chief Financial Officer Officer	5,000 -4.7% 85.78 USD 428,900	5,000 -4.7%	85.78	USD 428,900
2024-01-10	2024-01-09	PS Planned sale	Mercier Johanna Chief Commercial Officer Officer	8,242 -9.1% 85.23 USD 702,466	8,242 -9.1%	85.23	USD 702,466
2023-10-18	2023-10-17	PS Planned sale	Dickinson Andrew D Chief Financial Officer Officer	5,000 -4.6% 80.00 USD 400,017	5,000 -4.6%	80.00	USD 400,017
2023-09-13	2023-09-12	PS Planned sale	Parsey Merdad Chief Medical Officer Officer	1,501 -2.1% 76.99 USD 115,562	1,501 -2.1%	76.99	USD 115,562
2023-07-21	2023-07-20	PS Planned sale	Dickinson Andrew D Chief Financial Officer Officer	5,000 -4.4% 80.00 USD 400,000	5,000 -4.4%	80.00	USD 400,000
2023-06-14	2023-06-13	PS Planned sale	Parsey Merdad Chief Medical Officer Officer	1,485 -4.8% 76.90 USD 114,197	1,485 -4.8%	76.90	USD 114,197
2023-03-14	2023-03-13	PS Planned sale	Parsey Merdad Chief Medical Officer Officer	6,126 -8.0% 78.99 USD 483,893	6,126 -8.0%	78.99	USD 483,893
2023-03-02	2023-03-01	PS Planned sale	Parsey Merdad Chief Medical Officer Officer	12,984 -15.6% 79.96 USD 1,038,225	12,984 -15.6%	79.96	USD 1,038,225
2023-01-03	2022-12-30	PS Planned sale	Parsey Merdad Chief Medical Officer Officer	553 -1.2% 85.33 USD 47,187	553 -1.2%	85.33	USD 47,187
2022-11-10	2022-11-09	S Sale	Wilfong Diane E. SVP, Controller & CAO Officer	6,416 -18.5% 83.50 USD 535,736	6,416 -18.5%	83.50	USD 535,736
2022-11-02	2022-11-01	S Sale	Wilfong Diane E. SVP, Controller & CAO Officer	16,255 -36.5% 79.25 USD 1,288,209	16,255 -36.5%	79.25	USD 1,288,209
2022-03-14	2022-03-11	S Sale	Pletcher Brett A EVP,Corp Affairs & Gen Counsel Officer	3,634 -10.0% 58.24 USD 211,644	3,634 -10.0%	58.24	USD 211,644
2022-02-11	2022-02-09	PS Planned sale	Pletcher Brett A EVP,Corp Affairs & Gen Counsel Officer	1,691 -4.9% 63.89 USD 108,038	1,691 -4.9%	63.89	USD 108,038
2022-02-02	2022-02-01	PS Planned sale	Pletcher Brett A EVP,Corp Affairs & Gen Counsel Officer	14,061 -30.1% 68.54 USD 963,682	14,061 -30.1%	68.54	USD 963,682
2021-05-05	2021-05-04	S Sale	Mercier Johanna Chief Commercial Officer Officer	19,496 -70.7% 66.09 USD 1,288,547	19,496 -70.7%	66.09	USD 1,288,547
2021-05-04	2021-05-03	S Sale	Whitley Richard James Non-Executive Director	20,282 -39.5% 64.57 USD 1,309,655	20,282 -39.5%	64.57	USD 1,309,655
2021-03-12	2021-03-11	PS Planned sale	Pletcher Brett A EVP,Corp Affairs & Gen Counsel Officer	1,486 -4.8% 63.36 USD 94,153	1,486 -4.8%	63.36	USD 94,153
2021-02-11	2021-02-10	PS Planned sale	Pletcher Brett A EVP,Corp Affairs & Gen Counsel Officer	1,975 -6.4% 67.41 USD 133,135	1,975 -6.4%	67.41	USD 133,135
2021-02-03	2021-02-01	PS Planned sale	Pletcher Brett A EVP,Corp Affairs & Gen Counsel Officer	9,711 -25.2% 65.97 USD 640,633	9,711 -25.2%	65.97	USD 640,633
2020-08-19	2020-08-17	PS Planned sale	Parsey Merdad Chief Medical Officer Officer	182 -100.0% 68.32 USD 12,434	182 -100.0%	68.32	USD 12,434
2020-06-25	2020-06-23	S Sale	Rodriguez Javier Non-Executive Director	189 -100.0% 75.50 USD 14,270	189 -100.0%	75.50	USD 14,270
2020-05-07	2020-05-05	S Sale	Pletcher Brett A EVP,Corp Affairs & Gen Counsel Officer	13,210 -47.4% 79.23 USD 1,046,640	13,210 -47.4%	79.23	USD 1,046,640
2020-05-06	2020-05-04	S Sale	Wilfong Diane E. SVP, Controller & CAO Officer	12,264 -51.8% 80.09 USD 982,220	12,264 -51.8%	80.09	USD 982,220
2020-05-05	2020-05-04	S Sale	Cogan John Francis Non-Executive Director	2,416 -4.2% 81.75 USD 197,508	2,416 -4.2%	81.75	USD 197,508
2020-04-29	2020-04-27	S Sale	Cogan John Francis Non-Executive Director	2,413 -4.2% 79.90 USD 192,799	2,413 -4.2%	79.90	USD 192,799
2020-04-21	2020-04-20	S Sale	Cogan John Francis Non-Executive Director	2,413 -4.2% 83.00 USD 200,279	2,413 -4.2%	83.00	USD 200,279
2020-04-14	2020-04-13	S Sale	Cogan John Francis Non-Executive Director	2,413 -4.2% 75.90 USD 183,147	2,413 -4.2%	75.90	USD 183,147
2020-04-07	2020-04-06	S Sale	Cogan John Francis Non-Executive Director	2,413 -4.2% 79.52 USD 191,882	2,413 -4.2%	79.52	USD 191,882
2020-03-31	2020-03-30	S Sale	Cogan John Francis Non-Executive Director	2,413 -4.2% 75.35 USD 181,820	2,413 -4.2%	75.35	USD 181,820
2020-03-24	2020-03-23	S Sale	Cogan John Francis Non-Executive Director	2,413 -4.2% 75.27 USD 181,627	2,413 -4.2%	75.27	USD 181,627
2020-03-17	2020-03-16	S Sale	Cogan John Francis Non-Executive Director	2,413 -4.2% 67.26 USD 162,298	2,413 -4.2%	67.26	USD 162,298
2020-03-12	2020-03-10	PS Planned sale	Pletcher Brett A EVP,Corp Affairs & Gen Counsel Officer	2,950 -16.8% 75.55 USD 222,873	2,950 -16.8%	75.55	USD 222,873
2020-03-10	2020-03-09	S Sale	Cogan John Francis Non-Executive Director	2,413 -4.2% 77.97 USD 188,142	2,413 -4.2%	77.97	USD 188,142
2020-03-03	2020-03-02	PS Planned sale	Pletcher Brett A EVP,Corp Affairs & Gen Counsel Officer	1,100 -7.0% 71.26 USD 78,383	1,100 -7.0%	71.26	USD 78,383
2020-03-03	2020-03-02	PS Planned sale	Pletcher Brett A EVP,Corp Affairs & Gen Counsel Officer	9,341 -37.2% 70.83 USD 661,631	9,341 -37.2%	70.83	USD 661,631
2020-02-12	2020-02-10	S Sale	Pletcher Brett A EVP,Corp Affairs & Gen Counsel Officer	2,950 -10.7% 69.32 USD 204,494	2,950 -10.7%	69.32	USD 204,494
2020-02-11	2020-02-10	S Sale	WILSON GAYLE E Non-Executive Director	21,720 -14.6% 67.72 USD 1,470,878	21,720 -14.6%	67.72	USD 1,470,878
2020-02-10	2020-02-07	S Sale	Pletcher Brett A EVP,Corp Affairs & Gen Counsel Officer	1,426 -5.5% 70.00 USD 99,820	1,426 -5.5%	70.00	USD 99,820
2020-02-10	2020-02-07	S Sale	WOLD OLSEN PER Non-Executive Director	20,282 -17.2% 69.00 USD 1,399,458	20,282 -17.2%	69.00	USD 1,399,458
2020-02-10	2020-02-06	S Sale	Pletcher Brett A EVP,Corp Affairs & Gen Counsel Officer	5,000 -16.8% 68.18 USD 340,901	5,000 -16.8%	68.18	USD 340,901
2020-02-10	2020-02-06	S Sale	WOLD OLSEN PER Non-Executive Director	21,720 -18.2% 68.12 USD 1,479,605	21,720 -18.2%	68.12	USD 1,479,605
2020-01-06	2020-01-03	S Sale	Pletcher Brett A EVP,Corp Affairs & Gen Counsel	2,950 -14.7% 64.63 USD 190,659	2,950 -14.7%	64.63	USD 190,659
2019-12-04	2019-12-03	S Sale	Pletcher Brett A EVP,Corp Affairs & Gen Counsel Officer	5,900 -25.7% 65.77 USD 388,043	5,900 -25.7%	65.77	USD 388,043
2019-11-26	2019-11-25	S Sale	Pletcher Brett A EVP,Corp Affairs & Gen Counsel Officer	15,000 -46.8% 66.85 USD 1,002,809	15,000 -46.8%	66.85	USD 1,002,809
2019-11-20	2019-11-19	S Sale	Pletcher Brett A EVP,Corp Affairs & Gen Counsel	10,000 -36.9% 64.91 USD 649,062	10,000 -36.9%	64.91	USD 649,062
2019-11-20	2019-11-18	S Sale	Pletcher Brett A EVP,Corp Affairs & Gen Counsel	10,000 -36.9% 63.85 USD 638,500	10,000 -36.9%	63.85	USD 638,500

Gilead Sciences Inc (GILD)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by